Theratechnologies (TH.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
| 11-2017 | 08-2017 | 05-2017 | 02-2017 | 11-2016 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 350 | 390 | 383 | 382 | 407 |
| Accounts receivable | -644 | -944 | -1,366 | 443 | 338 |
| Other Working Capital | 3,487 | 448 | 2,893 | 1,380 | 460 |
| Other Operating Activity | -1,679 | -1,458 | -1,976 | -264 | 795 |
| Operating Cash Flow | $1,514 | $-1,565 | $-65 | $1,941 | $2,001 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 1 | 0 | -31 | N/A | 1 |
| Purchase Of Investment | -7,222 | -8,578 | -12,226 | -11,871 | -6,224 |
| Sale Of Investment | 5,595 | 5,532 | 10,293 | 2,949 | 4,831 |
| Purchase Sale Intangibles | -4 | -6 | -30 | N/A | 31 |
| Investing Cash Flow | $-1,631 | $-3,052 | $-1,993 | $-8,922 | $-1,362 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | -250 | 0 | N/A | 12,509 | 0 |
| Other Financing Activity | 67 | 2,045 | -312 | -816 | 206 |
| Financing Cash Flow | $-182 | $2,045 | $-312 | $11,693 | $206 |
| Exchange Rate Effect | 662 | 364 | 4 | -10 | 0 |
| Beginning Cash Position | 1,020 | 3,227 | 5,390 | 803 | 244 |
| End Cash Position | 1,368 | 1,020 | 3,023 | 5,505 | 788 |
| Net Cash Flow | $-299 | $-2,571 | $-2,370 | $4,712 | $845 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,514 | -1,565 | -65 | 1,941 | 2,001 |
| Capital Expenditure | -3 | -6 | -61 | N/A | N/A |
| Free Cash Flow | 1,511 | -1,570 | -126 | 1,941 | 2,001 |